By Peter Ungphakorn
POSTED MAY 7, 2021 | UPDATED FEBRUARY 6, 2022
It’s tempting to conclude that the proposed waiver on World Trade Organization (WTO) intellectual property rules related to the COVID-19 pandemic will swiftly be agreed now that the US is supporting it.
It’s also tempting to assume that if the waiver is agreed, then intellectual property on vaccines and other COVID-19 products will be freely available and in use around the world.
Neither of those will necessarily happen, and almost certainly not quickly.Continue reading “The proposed COVID-19 intellectual property waiver: too soon to predict”